FDAnews
www.fdanews.com/articles/149196-fda-to-industry-more-is-better-when-telling-agency-of-manufacturing-change

FDA to Industry: More Is Better When Telling Agency of Manufacturing Change

September 5, 2012
FDA officials sounded a familiar drumbeat during a Tuesday meeting on ways to notify the agency about changes to PMA products, asking devicemakers to submit more complete information upfront to ensure their submissions can be processed quickly. The joint FDA-AdvaMed meeting at the agency’s White Oak, Md., headquarters was held in advance of a planned pilot program that will transfer reviews of cardiovascular device submissions, such as annual reports and 30-day notices, from the Office of Compliance to the Office of Device Evaluation.
Devices & Diagnostics Letter